Antimicrobial peptides - Their role in immunity and therapeutic potential

Central-European Journal of Immunology

Volumn 28, Issue 3, 2003, Pages 138-141

  Gałkowska, Hanna ^a   Olszewski, Waldemar L ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Antimicrobial peptides; Immunity

Indexed keywords

ALPHA DEFENSIN; ANTIINFECTIVE AGENT; BACTERIUM LIPOPOLYSACCHARIDE; BETA DEFENSIN; CAP 18; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CATHELIN; CATHELIN RELATED ANTIMICROBIAL PEPTIDE; CATHEPSIN G; CEPHALOSPORIN DERIVATIVE; COLISTIN; CYCLOSPORIN; CYSTEINE; DEFENSIN; DEFENSIN 1; DEFENSIN 2; DEFENSIN 3; HISTAMINE; HUMAN NEUTROPHIL PEPTIDE 4; INTERLEUKIN 1; LACTOFERRIN; LYSOZYME; MAGAININ DERIVATIVE; MESSENGER RNA; NEOMYCIN; OFLOXACIN; PENICILLIN DERIVATIVE; PEPTIDE DERIVATIVE; PEPTIDE SYNTHASE; PEXIGANAN; PMAP 23; POLYMYXIN B; POLYPEPTIDE ANTIBIOTIC AGENT; PR 39; PROTEGRIN; RL 37; SMAP 29; SMAP 34; SOMATOMEDIN C; TRIPEPTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIVIRAL ACTIVITY; CELL PROLIFERATION; CHEMOTAXIS; CLINICAL TRIAL; CYTOKINE RELEASE; CYTOLYSIS; DISULFIDE BOND; DRUG STRUCTURE; EPITHELIUM CELL; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY CELL; INNATE IMMUNITY; NONHUMAN; REVIEW; STRUCTURE ANALYSIS; WOUND HEALING;

EID: 20444504350     PISSN: 14263912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Zasloff M (2002): Antimicrobial peptides of multicellular organisms. Nature 415 (6870): 389-395.
2. Evans ME, Feola DJ, Rapp RP (1999): Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram- negative bacteria. Ann Pharmacother 33 (9): 960-967.
3. Zhang J, Demain AL (1992): ACV synthetase. Crit Rev Biotechnol 12 (3): 245-260.
4. Hancock RE (1997): Peptide antibiotics. Lancet 349 (9049): 418-422.
5. Raj PA, Dentino AR (2002): Current status of defensins and their role in innate and adoptive immunity. FEMS Microbiol Lett 206: 9-18.
6. Ganz T, Selsted ME, Szklarek D, et al. (1985): Defensins: natural peptide antibiotics of human neutrophils. J Clin Invest 76 (4): 1427-1435.
7. Selsted ME, Harwig SS, Ganz T, et al. (1985): Primary structures of three human neutrophil defensins. J Clin Invest 76 (4): 1436-1439.
8. Selsted ME, Miller SI, Menschen AH, Ouellette AJ (1992): Enteric defensins: antibiotic peptide components of intestinal host defense. J Cell Biol 118: 929-936.
9. Quayle AJ, Porter EM, Nussbaum AA, et al. (1998): Gene expression, immunolocalization and secretion of human defensin 5 in human female reproductive tract. Am J Pathol 152: 1247-1258.
10. Cunliffe RN, Rose FR, Keyte J, et al. (2001): Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease. Gut 48: 176-185.
11. Ashitani J, Mukae H, Hiratsuka T, et al. (2002): Elevated levels of α-defensins in plasma and BAL fluid of patients with active pulmonary tuberculosis. CHEST 121 (2): 519-526.
12. Thomas NJ, Carcillo JA, Doughty LA, et al. (2002): Plasma concentrations of defensins and lactoferrin in children with severe sepsis. Pediatr Infct Dis J 21 (1): 34-38.
13. Diamond G, Zasloff M, Eck H, et al. (1991): Tracheal antimicrobial peptide, a cysteine- rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of cDNA. Proc Natl Acad Sci USA 88: 3952-3956.
14. Bensch K, Raida M, Magert HJ, et al. (1995): hBD-1: a novel β-defensin from human plasma. FEBS Lett 368: 331-335.
15. McCray JP, Bentley L (1997): Human airway epithelia express a beta-defensin. Am J Respir Cell Mol Biol 16 (3): 343-349.
16. Valore EV, Park CH, Quayale AJ, et al. (1998): Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest 101 (8): 1633-1642.
17. Fulton C, Anderson GM, Zasloff M, et al. (1997): Expression of natural peptide antibiotics in human skin. The Lancet 350: 1750-1751.
18. Ali RS, Falconer A, Ikram M, et al. (2001): Expression of the peptide antibiotics human β defensin-1 and human β defensin-2 in normal human skin. J Invest Dermatol 117: 106-111.
19. Harder J, Bartels J, Christofers E, Schroeder JM (1997): A peptide antibiotic from human skin (letter). Nature 387: 861.
20. Liu AY, Destoumieux D, Wong AV, et al. (2002): Human β defensin-2 production in keratinocytes is regulated by IL1, bacteria, and the state of differentiation. J Invest Dermatol 118: 275-281.
21. Dinulos JGH, Mentele L, Fredericks LP, et al. (2003): Keratinocyte expression of human β defensin 2 following bacterial infection: role in cutaneous host defence. Clin Diagnost Lab Immunol 10 (1): 161-166.
22. Liu L, Roberts AA, Ganz T (2002): By IL1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide. J Immunol 170: 575-580.
23. Harder J, Bartels J, Christophers E, Schroeder JM (2001): Isolation and characterization of human β defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276 (8): 5707-5713.
24. Garcia JR, Krause A, Schulz S, et al. (2001): Human β defensin-4: a novel inducible peptide with a specific salt-sensitive spectrum of antimocrobial activity. FASEB J 15 (10): 1819-1821.
25. Schutte BC, Mitros JP, Bartllet JA, et al. (2002): Discovery of five conserved beta defensin gene clusters using a computational search strategy. Proc Natl Acad Sci USA 99 (4): 2129-2133.
26. Duits LA, Ravensbergen B, Rademaker M, et al. (2002): Expression of β defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunol 106: 517-525.
27. Tang YQ, Yaun J, Osapay G, et al. (1999): A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha defensins. Science 286: 498-502.
28. Zanetti M, Gennaro R, Romeo D (1995): Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 374: 1-5.
29. Zaiou M, Gallo RL (2002): Cathelicidins, essential gene - encoded mammalian antibiotics. J Mol Med 80: 549-561.
30. Sorensen O, Arnljots K, Cowland JB, et al. (1997): The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 90: 2796-2803.
31. Agerberth B, Charo J, Werr J, et al. (2000): The human antimicrobial and chemotactic peptides LL37 and α defensins are expressed by specific lymphocytes and monocytes populations. Blood 96: 3086-3093.
32. Bals R, Wang X, Zasloff M, Wilson JM (1998): The peptide antibiotic LL37/hCAP18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci USA 95: 9541-9546.
33. Frohm Nilsson M, Sandstedt B, Sorensen O, et al. (1999): The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with IL6. Infect Immunol 67: 2561-2566.
34. Hase K, Eckmann L, Leopard JD, et al. (2002): Cell differntiation is a key determinant of cathelicidin LL37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun 70 (2): 953-963.
35. Frohm M., Agerberth B, Ahangari G, et al. (1997): The expression of the gene coding for the antibacterial peptide LL37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 272 (24): 15258-15263.
36. Ong PY, Ohtake T, Brandt C, et al. (2002): Endogenous antimicrobial peptides and skin infections in atopic dermatitis. Nengl J Med 347 (15): 1151-1160.
37. Dorschner RA, Pestonjamasp VK, Tamakuwala S, et al. (2001): Cutaneous injury induces the release of cathelicidin antimicrobial peptides active against group A Streptococcus. J Invest Dermatol 117: 91-97.
38. Sorensen OE, Cowland JB, Theilgaard-Monch K, et al. (2003): Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 170: 5583-5589.
39. Sorensen O, Bratt T, Johnsen AH, et al. (1999): The human antibacterial cathelicidin, hCAP18, is bound to lipoproteins in plasma. J Biol Chem 274: 22445-22451.
40. Gallo RL, Kim KJ, Bernfield M, et al. (1997): Identification of CRAMP, a cathelin related antimicrobial peptide expressed in the embryonic and adult mouse. J Biol Chem 272: 13088-13093.
41. Nizet V, Ohtake T, Lauth X, et al. (2001): Innate abtimicrobial peptide protects the skin from invasive bacterial infection. Nature 414: 454-457.
42. Dorschner RA, Lin KH, Murakami M, Gallo RL (2003): Neonatal skin in mice and humans expresses increased levels of antimicrobial peptides: innate immunity during development of the adaptive response. Pediatr Res 53 (4): 566-572.
43. Jia HP, Stamer T, Ackermann M, et al. (2001): Abundant human beta defensin 1 expression in milk and mammary gland epithelium. J Pediatr 138: 109-112.
44. Befus AD, Mowat C, Gilchrist M, et al. (1999): Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action. J Immunol 163: 947-953.
45. Niyonsaba F, Someya A, Hirata M, et al. (2001): Evolution of the effect of peptide antibiotics human beta defensin 2 and LL37 on histamine release and prostaglandin D2 production from mast cells. Eur J Immunol 31: 1066-1075.
46. Territo MC, Ganz T, Selsted ME, Lehler R (1989): Monocyte-chemotactic activity of defensins from human neutrophils. J Clin Invest 84: 2017-2020.
47. Yang D, Chertov O, Bykovskaia SN, et al. (1999): β defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286: 525-528.
48. Yang D, Chen Q, Chertov O, et al. (2000): Human neutrophil defensins selectively chemoattract naive and immature dendritic cells. J Lukocyte Biol 68: 9-14.
49. Biragyn A, Ruffini PA, Leiter CA, et al. (2002): Toll-like receptor 4-dependent activation of dendritic cells by β defensin 2. Science 298: 1025-1029.
50. Higazi A, Ganz T, Kariko K, Cines DB (1996): Defensin modulates tissue-type plasminogen activator and plasminogen binding to fibrin and endothelial cells. J Biol Chem 271 (30): 17650-17655.
51. Heilborn JD, Frohm Nilsson M, Kratz G, et al. (2003): The cathelicidin anti-microbial peptide LL37 is involved in re-epithelialization of human skin wound and its lacking in chronic ulcer epithelium. J Invest Dermatol 120: 379-389.
52. Jacob L, Zasloff M (1994): Potential therapeutic applications of magainins and other antimicrobial agents of animal origin. Ciba Found Symp 186: 197-216.
53. Mosca DA, Hurst MA, SO W, et al. (2000): IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis. Antimicrob Agents Chemother 44: 1803-1808.
54. Chen J, Falla TJ, Liu H, et al. (2000): Development of protegrins for the treatment and prevention of oral mucositis: structure-activity relationships of synthetic protegrin analogues. Biopolymers 55: 88-98.